| Mr Patrick Price Adams, LCSW SUDC | |
|
2870 E 3300 S, Millcreek, UT 84109-2821 | |
| (801) 500-3300 | |
| Not Available |
| Full Name | Mr Patrick Price Adams |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 2870 E 3300 S, Millcreek, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093051963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4942012-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Patrick Price Adams, LCSW SUDC 2870 E 3300 S, Millcreek, UT 84109-2821 Ph: (801) 500-3300 | Mr Patrick Price Adams, LCSW SUDC 2870 E 3300 S, Millcreek, UT 84109-2821 Ph: (801) 500-3300 |
News Archive
Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year's meeting is being held in Dresden, Germany, Sept. 13-16.
Integra LifeSciences Holdings Corporation announced today the launch of the Integra™ Endoscopic Gastroc Release (EGR) System in the United States. Integra's EGR System is a disposable device with a unique articulating blade that allows selective cutting of soft tissues. It is intended for use in the surgical treatment for posterior heel cord, or equinus, contracture.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
Amity Manning, assistant professor of biology and biotechnology, has received a three-year, $300,000 award from the Smith Family Awards Program for Excellence in Biomedical Research.
Over a two and half year period, beginning in 2005 when the U.S. Food and Drug Administration's oncology drug product's office began reviewing marketing applications, a total of 60 new oncology and hematology drugs were reviewed, of which 53 were approved, according to a new article published online January 29 in the Journal of the National Cancer Institute.
› Verified 7 days ago
Susan Michelle Bollow, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4444 S 700 E Ste 102, Millcreek, UT 84107 Phone: 385-321-3109 | |
Tyler Andrus, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4465 S 900 E Ste 150, Millcreek, UT 84124 Phone: 435-248-2089 | |
Lisa L Boice, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4064 S Highland Dr, Millcreek, UT 84124 Phone: 801-501-4350 | |
Ms. Shannon Penny Price, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4465 Maybeck Place, Condo C, Millcreek, UT 84124 Phone: 801-272-2807 | |
Rebecca Bowles, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4505 S Wasatch Blvd Ste 360a, Millcreek, UT 84124 Phone: 801-706-3677 | |
Denise Sanders, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1334 E Integra Ct, Millcreek, UT 84106 Phone: 801-449-0426 |